Search

everythinglearnresearchcommunity

for

Search:↓

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

Mice with CBS deficiency are healthier on a low-methionine diet.

HPV16 oncogenes disrupt the normal activity of hair follicle stem cells.

People with X-linked hypohidrotic ectodermal dysplasia have no sweat ducts and less, thinner hair.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

CT scans can find serious prostate cancer even when PSA levels are low.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Some common medications can lower PSA levels in 45-year-old German men.

Urinary PSA could be an early marker for enlarged prostate.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

PSA can help diagnose high androgen levels in women.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

PSA could be a marker for hyperandrogenism in women, but more research is needed.